febrile neutropenia development fever often signs infection patient neutropenia abnormally low number neutrophil granulocytes type white blood cell blood oncologic emergency common serious complication patients hematopoietic cancers receiving chemotherapy term neutropenic sepsis also applied although tends reserved patients less well cases infection detectable bacteremia bacteria bloodstream present approximately patients febrile neutropenia neutropenic fever defined single oral temperature value c f temperature c f hour absolute neutrophil count anc case severe neutropenia anc profoundly severe neutropenia anc fever febrile neutropenia develop form neutropenia generally recognized complication chemotherapy myelosuppressive suppresses bone marrow producing blood cellscitation needed febrile neutropenia common serious complication patients hematopoietic cancers receiving chemotherapy condition occurs neutropenic patient gets infected approximately patients febrile neutropenia develop infection profound neutropenia develop grampositive bacteria common pathogens causing febrile neutropenia many infections resulting longterm central venous multinational association supportive care cancer mascc risk index used identify lowrisk patients score points serious complications febrile neutropenia including death intensive care unit admission confusion cardiac complications respiratory failure kidney failure low blood pressure bleeding serious medical score developed select patients therapeutic strategies could potentially convenient costeffective prospective trial demonstrated modified mascc score identify patients febrile neutropenia low risk complications contrast clinical index stable febrile neutropenia cisne score specific patients solid tumors seemingly stable episodes cisne able discriminate groups patients low intermediate high risk complications population cisne complication rate determined lowrisk patients intermediaterisk patients highrisk prime purpose model avoid complications early hospital release contrary cisne used much select lowrisk patients outpatient generally patients febrile neutropenia treated empirical antibiotics neutrophil count recovered absolute neutrophil counts greater fever abated neutrophil count improve treatment may need continue two weeks occasionally cases recurrent persistent fever antifungal agent addedcitation needed guidelines issued infectious diseases society america recommend use particular combinations antibiotics specific settings mild lowrisk cases may treated combination oral amoxicillinclavulanic acid ciprofloxacin severe cases require cephalosporins activity pseudomonas aeruginosa eg cefepime carbapenems imipenem subsequent metaanalysis published found cefepime associated negative outcomes carbapenems causing higher rate pseudomembranous colitis straightforward updated guidelines issued infectious diseases society america recommending use cefepime carbapenems meropenem imipenemcilastatin piperacillintazobactam highrisk patients amoxicillinclavulanic acid ciprofloxacin lowrisk patients patients strictly fulfill criteria lowrisk patients admitted hospital treated highrisk patientscitation needed research compare antibiotic treatments currently recommended consensus identified studies comparing different antibiotics significantly higher mortality reported cefepime compared antibiotics combined piperacillintazobactam resulted lower mortality antibiotics piperacillintazobactam might preferred antibiotic treatment cancer patients fever neutropenia cefepime used empiric treatment started within minutes admitted periodic monitoring done see empiric treatment working target therapy people cancer febrile neutropenia excluding patients acute leukaemia oral treatment acceptable alternative intravenous antibiotic treatment hemodynamically stable without organ failure without pneumonia infection central line severe softtissue furthermore outpatient treatment febrile neutropenia people cancer probably makes little difference treatment failure mortality compared standard hospital inpatient treatment may reduce time patients need treated httpsenwikipediaorgwikifebrileneutropenia